Abstract
Head and neck squamous epithelial carcinogenesis is a complex multistep process that entails a progressive acquisition of alterations in diverse vital cellular pathways. The nature of these alterations and the order of their occurrence have remained unresolved. In the past 15 years, the thrust of research in this field has centered on the epithelial genetic and/or epigenetic changes attendant to their development and progression. Little efforts, however, have been expended on changes in structural or host microenvironment and their role in these tumors. Only recently has the latter topic become the focus of attention. This review will address recent advances in both cellular and structural findings in head and neck squamous carcinoma development and progression. Targeting these events for biological and therapeutic approaches is a desirable goal for future effective treatment of patients with this cancer.
Keywords: GSTP1 genotypes, DNA methylation, Epidermal Growth Factor, Angiogenesis, Epithelial-Mesenchymal Transformation, surrogate markers
Current Cancer Drug Targets
Title: Pathobiology of Head and Neck Squamous Tumorigenesis
Volume: 7 Issue: 7
Author(s): Adel K. El-Naggar
Affiliation:
Keywords: GSTP1 genotypes, DNA methylation, Epidermal Growth Factor, Angiogenesis, Epithelial-Mesenchymal Transformation, surrogate markers
Abstract: Head and neck squamous epithelial carcinogenesis is a complex multistep process that entails a progressive acquisition of alterations in diverse vital cellular pathways. The nature of these alterations and the order of their occurrence have remained unresolved. In the past 15 years, the thrust of research in this field has centered on the epithelial genetic and/or epigenetic changes attendant to their development and progression. Little efforts, however, have been expended on changes in structural or host microenvironment and their role in these tumors. Only recently has the latter topic become the focus of attention. This review will address recent advances in both cellular and structural findings in head and neck squamous carcinoma development and progression. Targeting these events for biological and therapeutic approaches is a desirable goal for future effective treatment of patients with this cancer.
Export Options
About this article
Cite this article as:
El-Naggar K. Adel, Pathobiology of Head and Neck Squamous Tumorigenesis, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418338
DOI https://dx.doi.org/10.2174/156800907782418338 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
Current Drug Targets Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers
Anti-Cancer Agents in Medicinal Chemistry Cancer Immunotherapy: Battling Tumors with Gene Vaccines
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Pulmonary Squamous Papilloma Complicating Recurrent Tracheal Papillomatosis
Current Respiratory Medicine Reviews Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets Updates of mTOR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry Methodological Issues of Clinical Research with EGFR Inhibitors
Current Cancer Therapy Reviews Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design Phytomedicines are Efficient Complementary Therapies for the Treatment of Atopic Dermatitis: A Review of Mechanistic Insight and Recent Updates
Current Drug Targets Recent Advances in Optical Cancer Imaging of EGF Receptors
Current Medicinal Chemistry Cell-Based Assay System to Estimate the Effect of 125I Seeds on Cancer Cells: Effect of Osteopontin
Recent Patents on Anti-Cancer Drug Discovery Dendrimer Based Formulation of Erlotiniib HCl: Development, Characterization and <i>In-Vitro</i> Evaluation
Pharmaceutical Nanotechnology H+-myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma
Current Cancer Drug Targets Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy
Protein & Peptide Letters